CAS: 1632463-24-1
Rivaroxaban Related Compound J
CAS:1632463-24-1
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi
Formula:
C38H36Cl2N6O10S2
Color and Shape:
Off-White Powder
Molecular weight:
870.13114
Estimated delivery in United States, on Thursday 14 Nov 2024
5-chloro-N-(4-((S)-5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-oxo-2-((((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)amino)ethoxy)ethyl)thiophene-2-carboxamide
CAS:1632463-24-1
Formula:
C38H36Cl2N6O10S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
871.7626
Ref: IN-DA00AQF8
Undefined size | To inquire |
Estimated delivery in United States, on Friday 15 Nov 2024
Rivaroxaban EP Impurity J (Rivaroxaban USP Related Compound J)
CAS:1632463-24-1
Formula:
C38H36Cl2N6O10S2
Color and Shape:
White To Off-White Solid
Molecular weight:
871.76
Ref: 4Z-R-2924
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 18 Nov 2024
Rivaroxaban Pseudodimer
Controlled ProductCAS:1632463-24-1
Formula:
C38H36Cl2N6O10S2
Color and Shape:
Neat
Molecular weight:
871.76
Ref: 86-MM3629.04-0025
25mg | 452.00 € |
Estimated delivery in United States, on Monday 18 Nov 2024
Rivaroxaban Pseudodimer
CAS:1632463-24-1
Applications Rivaroxaban Pseudodimer is an impurity of Rivaroxaban (R538000), a novel antithrombotic agent. A highly …
Formula:
C38H36Cl2N6O10S2
Color and Shape:
Neat
Molecular weight:
871.76
Ref: TR-R538015
10mg | 610.00 € | ||
25mg | 1,214.00 € | ||
50mg | 1,790.00 € |
Estimated delivery in United States, on Monday 25 Nov 2024
Rivaroxaban Pseudodimer
CAS:1632463-24-1
Please enquire for more information about Rivaroxaban Pseudodimer including the price, delivery time and more …
Formula:
C38H36Cl2N6O10S2
Purity:
Min. 95%
Molecular weight:
871.76 g/mol
Ref: 3D-HQC46324
1mg | 136.00 € | ||
2mg | 138.00 € | ||
5mg | 194.00 € | ||
10mg | 310.00 € | ||
25mg | 472.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024